| Literature DB >> 10930438 |
T D Camenisch1, A P Spicer, T Brehm-Gibson, J Biesterfeldt, M L Augustine, A Calabro, S Kubalak, S E Klewer, J A McDonald.
Abstract
We identified hyaluronan synthase-2 (Has2) as a likely source of hyaluronan (HA) during embryonic development, and we used gene targeting to study its function in vivo. Has2(-/-) embryos lack HA, exhibit severe cardiac and vascular abnormalities, and die during midgestation (E9.5-10). Heart explants from Has2(-/-) embryos lack the characteristic transformation of cardiac endothelial cells into mesenchyme, an essential developmental event that depends on receptor-mediated intracellular signaling. This defect is reproduced by expression of a dominant-negative Ras in wild-type heart explants, and is reversed in Has2(-/-) explants by gene rescue, by administering exogenous HA, or by expressing activated Ras. Conversely, transformation in Has2(-/-) explants mediated by exogenous HA is inhibited by dominant-negative Ras. Collectively, our results demonstrate the importance of HA in mammalian embryogenesis and the pivotal role of Has2 during mammalian development. They also reveal a previously unrecognized pathway for cell migration and invasion that is HA-dependent and involves Ras activation.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10930438 PMCID: PMC314332 DOI: 10.1172/JCI10272
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808